COVID-19 Targeted PCORI Funding Announcement (PFA) on May 5, 2020
This new research funding announcement has an accelerated timeline to support innovative, high-impact studies that fit clearly within our core mission of patient-engaged and patient-centered comparative clinical effectiveness research with up to $30 million funds available. The objectives of this announcement are to strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and provide evidence to inform clinical and public health responses, decision making, and planning.This funding announcement’s three targeted priority areas are:
- Adaptations to healthcare delivery
- Impact of COVID-19 on vulnerable populations
- Impact of COVID-19 on healthcare workforce well-being, management, and trainingWe invite you to review the full pre-announcement on the PCORI website for more information about this PFA.